— Know what they know.
Not Investment Advice
Also trades as: BLCO.TO (TSX) · $vol 0M

BLCO NYSE

Bausch + Lomb Corporation
1W: +1.4% 1M: -5.0% 3M: -0.1% YTD: +3.1% 1Y: +16.6% 3Y: +1.7%
$17.11
+0.17 (+1.00%)
 
Weekly Expected Move ±3.1%
$16 $17 $17 $18 $18
NYSE · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 39 · $6.1B mcap · 46M float · 0.900% daily turnover · Short 57% of daily vol

Cash Flow Trends

Operating Cash Flow
$283M +22.0% ▲
5Y CAGR: -11.5%
Capital Expenditures
$349M -19.9% ▼
5Y CAGR: +6.1%
Free Cash Flow
-$66M -11.9% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
$81M +550.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$193M$15M-$248M-$305M-$352M
Depreciation & Amort.$415M$379M$382M$436M$421M
Stock-Based Comp.$62M$62M$74M$92M$149M
Change in Working Capital$28M-$19M-$287M-$87M$18M
Other Non-Cash Items$59M-$2M$72M$106M$79M
Operating Cash Flow$873M$345M-$17M$232M$283M
— Investing Activities —
Capital Expenditures-$193M-$175M-$181M-$291M-$349M
Acquisitions (Net)-$16M$45M-$1.9B$0$0
Investment Purchases-$19M-$62M-$17M-$12M-$11M
Investment Sales$14M$22M$16M$14M$8M
Other Investing$0-$45M$14M-$123M-$103M
Investing Cash Flow-$214M-$215M-$2.1B-$412M-$455M
— Financing Activities —
Net Debt Issuance$28M$2.5B$2.1B$201M$249M
Stock Repurchased$0$0$0-$12M$0
Dividends Paid$0$0$0$0$0
Other Financing-$740M-$2.4B-$37M-$11M-$24M
Financing Cash Flow-$712M$81M$2.1B$178M$225M
Net Change in Cash-$61M$203M-$46M-$18M$81M
Cash End of Period$177M$380M$334M$316M$397M
Free Cash Flow$680M$170M-$198M-$59M-$66M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms